Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Pulmonary Hypertension

  Free Subscription


2 Am J Respir Cell Mol Biol
2 Am J Respir Crit Care Med
1 BMJ Case Rep
1 Cardiovasc Res
1 Case Rep Pulmonol
2 Circ Cardiovasc Imaging
1 Cureus
1 Curr Opin Nephrol Hypertens
1 Curr Opin Pulm Med
1 Eur J Cardiothorac Surg
1 Eur J Case Rep Intern Med
1 Expert Rev Respir Med
1 Nat Commun
1 PLoS One
1 Pneumologie
1 Prostaglandins Leukot Essent Fatty Acids
1 Rev Esp Cardiol (Engl Ed)
1 Transplant Proc
1 Zhonghua Yi Xue Za Zhi

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Respir Cell Mol Biol

    The Unsettling Ambiguity of Therapeutic Extracellular Vesicles from Mesenchymal Stromal Cells.
    Am J Respir Cell Mol Biol. 2020;62:539-540.

    Targeting Vessel Formation in Pulmonary Arterial Hypertension: Is the Endostatin-Id1-Thrombospondin 1 Pathway a New Hope?
    Am J Respir Cell Mol Biol. 2020;62:411-412.

    Am J Respir Crit Care Med

  3. ZAMANIAN RT, Pollack CV Jr, Gentile MA, Rashid M, et al
    Outpatient Inhaled Nitric Oxide in a Patient with Vasoreactive IPAH and COVID-19 Infection.
    Am J Respir Crit Care Med. 2020 May 5. doi: 10.1164/rccm.202004-0937.

  4. RUOPP NF, Farber HW
    The Elephant Man Meets Pulmonary Hypertension: A Cautionary Tale.
    Am J Respir Crit Care Med. 2020 Jul 15. doi: 10.1164/rccm.202006-2142.

    BMJ Case Rep

  5. COELHO SG, Loureiro MJ
    Neurofibromatosis-associated pulmonary hypertension: an ominous duo.
    BMJ Case Rep. 2020;13.
    PubMed         Abstract available

    Cardiovasc Res

  6. CHAUMAIS MC, Djessas MRA, Thuillet R, Cumont A, et al
    Additive Protective Effects of Sacubitril/Valsartan and Bosentan on Vascular Remodeling in Experimental Pulmonary Hypertension.
    Cardiovasc Res. 2020 Jul 11. pii: 5870372. doi: 10.1093.
    PubMed         Abstract available

    Case Rep Pulmonol

  7. MUBASHER M, Hanafi A, Syed T, Zinal A, et al
    Postpartum Pulmonary Hypertension Masquerading as Submassive Pulmonary Embolism: A Case Report and a Literature Review.
    Case Rep Pulmonol. 2020;2020:8899562.
    PubMed         Abstract available

    Circ Cardiovasc Imaging

  8. DONG Y, Pan Z, Wang D, Lv J, et al
    Prognostic Value of Cardiac Magnetic Resonance-Derived Right Ventricular Remodeling Parameters in Pulmonary Hypertension: A Systematic Review and Meta-Analysis.
    Circ Cardiovasc Imaging. 2020;13:e010568.
    PubMed         Abstract available

  9. OSTENFELD E, Kjellstrom B
    The Conundrum of Right Ventricular Remodeling and Outcome in Pulmonary Hypertension.
    Circ Cardiovasc Imaging. 2020;13:e011208.


  10. HUSSAIN H, Espinosa R, Chittivelu S
    Multifactorial Pulmonary Hypertension in Systemic Sclerosis.
    Cureus. 2020;12:e9144.
    PubMed         Abstract available

    Curr Opin Nephrol Hypertens

  11. EDMONSTON DL, Sparks MA
    Therapeutic options for chronic kidney disease-associated pulmonary hypertension.
    Curr Opin Nephrol Hypertens. 2020 Jul 9. doi: 10.1097/MNH.0000000000000624.
    PubMed         Abstract available

    Curr Opin Pulm Med

  12. HARDER EM, Waxman AB
    Clinical trials in group 3 pulmonary hypertension.
    Curr Opin Pulm Med. 2020 Jul 9. doi: 10.1097/MCP.0000000000000694.
    PubMed         Abstract available

    Eur J Cardiothorac Surg

    Implications of haemodynamic monitoring during left ventricular assist device support.
    Eur J Cardiothorac Surg. 2020;57:410.

    Eur J Case Rep Intern Med

  14. VAN DONGEN CM, Janssen MT, van der Horst RP, van Kraaij DJ, et al
    Unusually Rapid Development of Pulmonary Hypertension and Right Ventricular Failure after COVID-19 Pneumonia.
    Eur J Case Rep Intern Med. 2020;7:001784.
    PubMed         Abstract available

    Expert Rev Respir Med

  15. GAIKWAD AV, Eapen MS, McAlinden KD, Chia C, et al
    Endothelial to mesenchymal transition (EndMT) and vascular remodelling in pulmonary hypertension and idiopathic pulmonary fibrosis.
    Expert Rev Respir Med. 2020 Jul 13. doi: 10.1080/17476348.2020.1795832.
    PubMed         Abstract available

    Nat Commun

  16. MEI L, Zheng YM, Song T, Yadav VR, et al
    Rieske iron-sulfur protein induces FKBP12.6/RyR2 complex remodeling and subsequent pulmonary hypertension through NF-kappaB/cyclin D1 pathway.
    Nat Commun. 2020;11:3527.
    PubMed         Abstract available

    PLoS One

  17. HILDE JM, Hisdal J, Skjorten I, Hansteen V, et al
    Left ventricular dysfunction in COPD without pulmonary hypertension.
    PLoS One. 2020;15:e0235075.
    PubMed         Abstract available


  18. LANGE TJ, Borst M, Ewert R, Halank M, et al
    [Current Aspects of Definition and Diagnosis of Pulmonary Hypertension].
    Pneumologie. 2020 Jul 14. doi: 10.1055/a-1199-1548.
    PubMed         Abstract available

    Prostaglandins Leukot Essent Fatty Acids

  19. OZEN G, Amgoud Y, Abdelazeem H, Mani S, et al
    Downregulation of PGI2 pathway in Pulmonary Hypertension Group-III patients.
    Prostaglandins Leukot Essent Fatty Acids. 2020;160:102158.
    PubMed         Abstract available

    Rev Esp Cardiol (Engl Ed)

  20. MARTINEZ-SANTOS P, Velazquez-Martin MT, Barbera JA, Fernandez Perez C, et al
    Chronic thromboembolic pulmonary hypertension in Spain: a decade of change.
    Rev Esp Cardiol (Engl Ed). 2020 Jul 9. pii: S1885-5857(20)30258.
    PubMed         Abstract available

    Transplant Proc

  21. OBI C, Frost AE, Graviss EA, Nguyen DT, et al
    The Association of Pretransplant Pulmonary Hypertension With Patient and Graft Survival After Kidney Transplantation: A Retrospective Cohort Study.
    Transplant Proc. 2020 Jul 11. pii: S0041-1345(20)30341.
    PubMed         Abstract available

    Zhonghua Yi Xue Za Zhi

  22. XIE WM, Liu M, Yang HW, Tao XC, et al
    [Imaging findings of CT pulmonary angiography in patients with chronic thromboembolic pulmonary hypertension].
    Zhonghua Yi Xue Za Zhi. 2020;100:2012-2017.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.